NYSE$AMWL

American Well Corp · Q3 2025 earnings

Q3 2025 earnings · · After market close · Investor relations

Briefing

American Well reported Q3 2025, revenue of $56.3M, a net loss of $32.4M.

For Q3 2025, American Well reported revenue of $56.3M, a net loss of $32.4M. Management discussed operating trends, liquidity, and priorities as disclosed in the quarterly filing.

  • Revenue $56.3M.
  • Net loss $32.4M.
  • American Well updated strategic and capital priorities in the filing.

Headline financials

Total Revenue

$56.3M

Previous: $61M-7.8%
EPS

-$2.00

Previous: -$2.87+30.3%
Capital Expenditures

-$9K

Previous: -$116K+92.2%
Free Cash Flow

-$32.4M

Previous: -$43.6M+25.7%
Net Income

-$32.4M

Previous: -$43.5M+25.5%
Operating Income

-$29.3M

Previous: -$47.4M+38.1%
Gross Profit

-$29.3M

Previous: -$47.4M+38.1%

Revenue & EPS history

American Well · Revenue · Quarterly

$56.3M

Q3 2025-7.8%vs Q3 2024
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Revenue by segment

American Well · $28.4M total across 1 segment · Q3 2023

  • Subscription Revenue
    $28.4M-11.0%

Forward guidance

The filing discusses American Well's outlook, capital deployment, and key risks without relying solely on numeric EPS guidance.

Tailwinds

  • American Well cited execution on strategic priorities in the filing.
  • Balance sheet and liquidity support continued operations.
  • Pipeline milestones and partnerships remain key value drivers.

Headwinds

  • GAAP profitability remained under pressure in the quarter.
  • Macro, competitive, and cost pressures may affect margins.
  • Segment mix and one-time items can affect comparability.
  • Clinical or pre-commercial spend continues ahead of sustainable revenue.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2025

Historical avgQ3 2025

+1.4%

Avg return

Earnings day

+2.1%

Avg return

5 days after

-2.2%

Avg return

30 days after

41%

9 / 22 earnings

Positive

+33.8%

Q2 2024

Best reaction

-20.9%

Q1 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.0%+27.2%+34.0%
Q4 2025+24.7%+34.9%+29.8%
Q3 2025-9.5%-20.0%-20.6%
Q1 2025+19.7%+9.5%+8.9%
Q4 2024-5.0%-3.6%-35.5%
Q3 2024-5.0%-5.4%-0.7%
Q2 2024+33.8%+13.9%-1.1%
Q1 2024+2.0%+11.4%-16.3%
Q4 2023+23.6%+20.8%-16.0%
Q3 2023+14.5%+4.3%+11.1%
Q2 2023-8.3%-13.9%-35.2%
Q1 2023-3.9%-2.9%+17.9%
Q4 2022-13.1%-19.2%-37.3%
Q3 2022-2.2%+14.9%-8.3%
Q2 2022+9.2%+6.8%-4.8%
Q1 2022-10.8%+8.8%+37.6%
Q4 2021+7.2%+1.0%-8.0%
Q3 2021-7.4%-3.7%-29.7%
Q2 2021+0.7%-1.7%+0.8%
Q1 2021-20.9%-5.7%+9.5%
Q4 2020-4.1%-10.8%-1.5%
Q3 2020-11.9%-19.8%+17.1%
Q2 2020
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro